Trump Administration Appeals Court Ruling Blocking RFK Jr.'s Vaccine Schedule Overhaul

• The FDA extended its review of a supplemental biologics license application (sBLA) submitted by Eisai and Biogen on May 8, 2026. • The application concerns a once-weekly subcutaneous autoinjector starting regimen for lecanemab-irmb (Leqembi Iqlik), used to treat early Alzheimer disease.

• Artificial intelligence is being utilized to advance the early detection and management of complex diseases, specifically genetic and neurodegenerative disorders. • Prof. Dr. Ajith Abraham, Vice Chancellor and Dean of the School of AI at Sai University in Chennai, is leading these efforts through extensive research publications.

• The Connecticut Office of Health Strategy (OHS) has released a preliminary list of outpatient prescription drugs provided at a substantial cost for the 2026 reporting cycle. • The report details the highest-cost outpatient drugs, including total costs, utilization rates across commercial, Medicaid, and Medicare Advantage markets, and wholesale acquisition cost increases.

• The U.S. administration has implemented strict travel restrictions, including banning entry for individuals from countries experiencing Ebola outbreaks and blocking infected U.S. citizens from returning home for treatment. • Additionally, federal officials imposed mandatory quarantine orders on two passengers from a cruise ship affected by hantavirus.

• The U.S. government issued a joint statement reaffirming its commitment to protecting public health through sound science, transparency, and independent review. • The statement specifically addresses concerns raised by scientists and policymakers regarding the consistency and real-world applicability of cancer hazard assessments conducted by the International Agency for Research on Cancer (IARC).

• Researchers have developed a new urine test that identifies children likely to have autism by analyzing specific gut microbe profiles. • According to a study published in Molecular Psychiatry, the test correctly identified 90% of autistic children without misidentifying any neurotypical children.

• Regulators from the AMA and EMA have launched clinical trials in the Democratic Republic of the Congo and Uganda to combat the Bundibugyo Ebola virus. • The trials will test three vaccines—including mRNA, modified VSV, and ChAdOx1 adenovirus options—alongside various monoclonal antibody treatments and antiviral drugs.

• The drug discovery technology market is projected to grow significantly, with its total size expected to surpass USD 80.27 billion by 2035. • Growth is primarily driven by the integration of genomic data and testing, which allow researchers to identify novel drug targets and analyze DNA variations.

• A retrospective of 2025's top infectious disease reports highlights critical events including a tuberculosis outbreak in Kansas City and a significant FDA drug approval. • The Trump administration's termination of NIH grants severely disrupted clinical trials, with infectious disease research identified as the most heavily impacted sector.

• The Vanderbilt Report's weekly briefing for June 1–8, 2026, highlights several major medical breakthroughs, including new findings regarding GLP-1 weight-loss drugs. • Key developments include the discovery of a "striking new cancer signal" associated with GLP-1 medications and the emergence of a one-shot gene editing infusion.

• A wave of high-profile resignations and firings has created a leadership vacuum at the top of the CDC and FDA. • These departures suggest the Trump administration may be pivoting away from specific goals of the "Make America Healthy Again" (MAHA) movement.

• The World Health Organization (WHO) has declared the Ebola outbreak a public health emergency, prompting employers to review operational and workforce safety considerations. • While the risk to the general population in Europe remains very low, individuals returning from affected areas are advised to seek medical care if symptoms appear within 21 days.